BPMC logo

Blueprint Medicines (BPMC) Retained Earnings

Annual Retained Earnings

-$2.41 B
-$67.09 M-2.87%

December 31, 2024


Summary


Performance

BPMC Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Quarterly Retained Earnings

-$2.41 B
-$49.95 M-2.12%

December 31, 2024


Summary


Performance

BPMC Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BPMC Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.9%-4.6%
3 y3 years-88.7%-4.6%
5 y5 years-154.7%-4.6%

BPMC Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-88.7%at low-88.7%at low
5 y5-year-281.3%at low-341.1%at low
alltimeall time-5641.8%at low-2828.1%at low

Blueprint Medicines Retained Earnings History

DateAnnualQuarterly
Dec 2024
-$2.41 B(+2.9%)
-$2.41 B(+2.1%)
Sep 2024
-
-$2.36 B(+2.4%)
Jun 2024
-
-$2.30 B(+2.2%)
Mar 2024
-
-$2.25 B(-3.8%)
Dec 2023
-$2.34 B(+27.7%)
-$2.34 B(+5.0%)
Sep 2023
-
-$2.23 B(+6.4%)
Jun 2023
-
-$2.10 B(+6.8%)
Mar 2023
-
-$1.96 B(+7.1%)
Dec 2022
-$1.83 B(+43.7%)
-$1.83 B(+9.5%)
Sep 2022
-
-$1.67 B(+8.6%)
Jun 2022
-
-$1.54 B(+11.6%)
Mar 2022
-
-$1.38 B(+8.3%)
Dec 2021
-$1.28 B(+102.0%)
-$1.28 B(+33.3%)
Sep 2021
-
-$956.75 M(+14.0%)
Jun 2021
-
-$839.51 M(+14.8%)
Mar 2021
-
-$731.07 M(+15.8%)
Dec 2020
-$631.36 M(-33.2%)
-$631.36 M(+15.7%)
Sep 2020
-
-$545.69 M(-53.7%)
Jun 2020
-
-$1.18 B(+11.7%)
Mar 2020
-
-$1.06 B(+11.7%)
Dec 2019
-$945.24 M
-$945.24 M(+7.5%)
DateAnnualQuarterly
Sep 2019
-
-$878.91 M(+12.0%)
Jun 2019
-
-$784.63 M(+14.6%)
Mar 2019
-
-$684.95 M(+14.6%)
Dec 2018
-$597.54 M(+68.0%)
-$597.54 M(+15.5%)
Sep 2018
-
-$517.22 M(+16.4%)
Jun 2018
-
-$444.50 M(+6.5%)
Mar 2018
-
-$417.45 M(+17.4%)
Dec 2017
-$355.59 M(+71.4%)
-$355.59 M(+16.0%)
Sep 2017
-
-$306.56 M(+14.0%)
Jun 2017
-
-$268.86 M(+14.2%)
Mar 2017
-
-$235.45 M(+13.5%)
Dec 2016
-$207.47 M(+53.7%)
-$207.47 M(+11.4%)
Sep 2016
-
-$186.21 M(+9.9%)
Jun 2016
-
-$169.37 M(+12.6%)
Mar 2016
-
-$150.48 M(+11.5%)
Dec 2015
-$134.97 M(+64.2%)
-$134.97 M(+13.0%)
Sep 2015
-
-$119.40 M(+11.8%)
Jun 2015
-
-$106.76 M(+13.8%)
Mar 2015
-
-$93.78 M(+14.1%)
Dec 2014
-$82.21 M(+96.1%)
-$82.21 M
Dec 2013
-$41.92 M
-

FAQ

  • What is Blueprint Medicines annual retained earnings?
  • What is the all time high annual retained earnings for Blueprint Medicines?
  • What is Blueprint Medicines annual retained earnings year-on-year change?
  • What is Blueprint Medicines quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Blueprint Medicines?
  • What is Blueprint Medicines quarterly retained earnings year-on-year change?

What is Blueprint Medicines annual retained earnings?

The current annual retained earnings of BPMC is -$2.41 B

What is the all time high annual retained earnings for Blueprint Medicines?

Blueprint Medicines all-time high annual retained earnings is -$41.92 M

What is Blueprint Medicines annual retained earnings year-on-year change?

Over the past year, BPMC annual retained earnings has changed by -$67.09 M (-2.87%)

What is Blueprint Medicines quarterly retained earnings?

The current quarterly retained earnings of BPMC is -$2.41 B

What is the all time high quarterly retained earnings for Blueprint Medicines?

Blueprint Medicines all-time high quarterly retained earnings is -$82.21 M

What is Blueprint Medicines quarterly retained earnings year-on-year change?

Over the past year, BPMC quarterly retained earnings has changed by -$106.23 M (-4.62%)